ICD-10 Coding for Renal Angiomyolipoma(C64.9, C64.9U, D17.71)
Learn about the ICD-10 coding for renal angiomyolipoma, including primary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Renal Angiomyolipoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D17.71 | Benign lipomatous neoplasm of kidney | Use when imaging or pathology confirms a benign lipomatous neoplasm in the kidney. |
|
| D17.9 | Benign lipomatous neoplasm, unspecified | Use only when the specific location of the neoplasm is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutRenal Angiomyolipoma
Alternative codes to consider when ruling out similar conditions
Use only if pathology confirms malignancy.
Documentation & Coding Risks
Avoid these common issues when documenting Renal Angiomyolipoma.
Failing to document tuberous sclerosis association
Impact
Clinical: Missed opportunity for comprehensive care management., Regulatory: Non-compliance with coding standards., Financial: Potential loss of risk adjustment factor.
Mitigation
Review genetic testing results, Document any known genetic conditions
Using D17.9 when the location is specified
Impact
Reimbursement: May lead to incorrect DRG assignment and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation
Ensure documentation specifies the kidney as the location to use D17.71.
Incorrect use of unspecified codes
Impact
Using D17.9 when the location is specified can trigger audits.
Mitigation
Ensure documentation specifies the kidney as the location.